Additionally, two other B cell subsets (CD27+IgD+ NSw MBCs and CD19+B220+CD138+ PBs) were found in MASLD and HCC tissues, which might also play a protumorigenic role in liver disease progression. This evidence concerns the gene CD19 and liver disorder.